Calcium currents in bullfrog sympathetic neurons. I. Activation kinetics and pharmacology.

The Journal of General Physiology
S W Jones, T N Marks

Abstract

The calcium current of bullfrog sympathetic neurons activates and deactivates rapidly (tau less than 3 ms). For brief depolarizations, the current can be fit reasonably well by a Hodgkin-Huxley-type model with a single gating particle of charge +3. With 2 mM Ca2+ as the charge carrier, half-maximal activation occurs at approximately -5 mV, near the voltage where activation and deactivation are slowest. When extracellular divalent ion concentrations are reduced, monovalent ions (e.g., Na+ and methylammonium) produce kinetically similar inward currents. Current carried by Ba2+ is blocked by Cd2+ at micromolar concentrations, and by 100 nM omega-conotoxin. Commercially available saxitoxin blocks the current, but different batches have quantitatively different potency. The dihydropyridine agonist Bay K 8644 induces a slight shift in activation kinetics to more negative voltages, with little effect on the peak current. Nifedipine at least partially reverses the effect of Bay K 8644, but has little effect on its own. Muscarinic agonists and other ligands that inhibit the M-type potassium current of frog sympathetic neurons have weak inhibitory effects on the calcium current as well. One interpretation of these results is that the N-t...Continue Reading

References

Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·E W McCleskey, W Almers
Jun 1, 1986·Biophysical Journal·J M CaffreyA M Brown
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·E WankeJ Meldolesi
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·E W McCleskeyD Yoshikami
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D LipscombeR W Tsien
Aug 1, 1988·The Journal of General Physiology·D Swandulla, C M Armstrong
Jan 1, 1987·Annals of the New York Academy of Sciences·S W Jones
Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·T HoshiS J Smith
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·B P Bean
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
May 6, 1984·Nature·P Hess, R W Tsien

❮ Previous
Next ❯

Citations

Apr 1, 1990·Pflügers Archiv : European journal of physiology·E CarboneF Clementi
Nov 1, 1991·Pflügers Archiv : European journal of physiology·B S Jassar, P A Smith
Feb 1, 1994·Pflügers Archiv : European journal of physiology·N V Marrion
Sep 1, 1993·Pflügers Archiv : European journal of physiology·M A WerzS W Jones
Jun 1, 1993·Pflügers Archiv : European journal of physiology·K S ElmslieS W Jones
Feb 1, 1997·Molecular Neurobiology·G A Lnenicka, S J Hong
Feb 16, 2006·The Journal of Membrane Biology·D DíazJ C Gomora
Jan 1, 1989·Progress in Biophysics and Molecular Biology·E Carbone, D Swandulla
Feb 1, 1991·Trends in Neurosciences·D SwandullaH D Lux
Jul 1, 1994·Progress in Neurobiology·P A Smith
Jan 23, 1999·Journal of the Autonomic Nervous System·W KukwaP J Szulczyk
Aug 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·I M MintzB P Bean
Apr 1, 1995·The Journal of General Physiology·W Zhou, S W Jones
Jan 5, 1999·The Journal of General Physiology·H K Lee, K S Elmslie
Aug 29, 2001·The Journal of General Physiology·H T KurataD Fedida
Jul 2, 2008·The Journal of General Physiology·Hui SunNormand Leblanc
Jul 1, 1989·The Journal of General Physiology·S W Jones, T N Marks
Nov 13, 1990·European Journal of Biochemistry·D PietrobonT Pozzan
Aug 5, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Fujun LuoStephen D Meriney
Aug 13, 2014·The Journal of General Physiology·Zafir BuraeiKeith S Elmslie
Nov 28, 2006·Neuropharmacology·Zafir BuraeiKeith S Elmslie
Oct 20, 2011·Progress in Neurobiology·Henry C Tuckwell
May 8, 2009·Cell Calcium·Mandy L Roberts-CrowleyAnn R Rittenhouse
Jul 22, 2014·Progress in Neurobiology·Stephen D MerineyCameron B Gundersen
Oct 8, 2016·Environmental Toxicology and Pharmacology·Katie O'NeillAndrew Humpage
Feb 23, 2017·Basic & Clinical Pharmacology & Toxicology·Katie O'NeillAndrew Humpage

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.